Skip to main content
QuestionsResearchTagsGuidelinesLeaderboard
tachyDx Research Portal

Research tagged [critical-care]

Every paper is generated from a real clinical discussion on tachyDx, peer-reviewed by verified physicians, and published with a unique TDX identifier. All contributors are credited.

DOIs registered viaCrossref
Published26Under ReviewFlagged
Clear filters

7 papers

TDX-2026-00019

Management of Right Ventricular Dysfunction and Weaning Protocols for Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19 Acute Respiratory Distress Syndrome: A Clinical Consensus Initiative

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) provides crucial life support for severe acute respiratory distress syndrome (ARDS), including that caused by COVID-19. Weaning from VV-ECMO presents complex challenges, particularly concerning persistent right ventricular (RV) dysfunction, which can complicate decannulation decisions. This paper synthesizes expert clinical perspectives on VV-ECMO weaning criteria, focusing on RV assessment, sweep gas trial protocols, and the utility of inhaled pulmonary vasodilators. Utilizing a community peer-review platform, two critical care physicians provided detailed protocols and insights, which were subsequently validated by 84 peer votes. Key findings indicate a pragmatic approach to RV dysfunction, where mild residual impairment may be acceptable if gas exchange and hemodynamic stability are maintained. Staged sweep gas trials, extending up to 6 hours, are advocated, with continuous monitoring of respiratory mechanics, gas exchange, and hemodynamic parameters. The use of inhaled iloprost as a bridge therapy for residual pulmonary hypertension during decannulation was also explored. This initiative highlights the variability in current clinical practice and provides a consensus-driven framework to guide VV-ECMO weaning in patients with COVID-19 ARDS and RV dysfunction, emphasizing individualized patient assessment and a multidisciplinary approach.

A physician-only Q&A platform where verified medical doctors share clinical knowledge, debate evidence, and build the knowledge base the world needs.

Powered by

Platform

  • Questions
  • Research
  • Tags
  • Guidelines
  • Leaderboard
  • Report a Bug

Ecosystem

  • Teams
  • Sponsors
  • Hiring
  • Publishing
  • CME
  • Data

Company

  • About
  • Support
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 Aethryva Deeptech Pvt Ltd. All rights reserved.

Crossref Member
2 contributors 84 votes 9 Apr 2026

TDX-2026-00016

Optimizing Potassium Replacement and Insulin Initiation in Diabetic Ketoacidosis with Initial Hypokalemia: A Peer-Reviewed Clinical Consensus

Background: Diabetic ketoacidosis (DKA) is a severe metabolic emergency characterized by hyperglycemia, ketonemia, and acidosis. Despite the extracellular shift of potassium (K+) in acidosis, initial hypokalemia is observed in a significant proportion of DKA patients, indicating a profound total body K+ deficit. The timing of insulin initiation in such cases presents a critical clinical dilemma, balancing the urgent need for acidosis correction against the risk of precipitous K+ decline and subsequent cardiac arrhythmias. Methods: This consensus paper synthesizes expert opinion from two verified physicians within the tachyDx peer-review community, supported by 72 community peer votes. The discussion focused on a 28-year-old male presenting with DKA and initial serum K+ of 3.1 mEq/L. Key areas of inquiry included the aggressiveness and route of K+ replacement, concurrent K+ infusion rates with insulin, and the role of phosphate and magnesium supplementation. Results: A consensus emerged advocating for aggressive K+ replacement (e.g., 40 mEq KCl via central line over 1 hour) prior to insulin initiation, with a recommended threshold of K+ ≥ 3.5 mEq/L. Central venous access was preferred for high-rate infusions, with peripheral alternatives outlined. Concurrent K+ infusion at 20-40 mEq/hr was advised during insulin therapy, targeting serum K+ of 4.0-5.0 mEq/L. Modified insulin dosing (0.05 units/kg/hr) was suggested for K+ < 3.5 mEq/L. The importance of magnesium monitoring and replacement, alongside judicious potassium phosphate use for hypophosphatemia, was emphasized. Bicarbonate administration was generally discouraged. Conclusions: This peer-reviewed consensus provides practical, evidence-informed guidance for managing initial hypokalemia in DKA. The recommendations prioritize patient safety by mitigating arrhythmia risk while facilitating timely DKA resolution, offering a refined approach to electrolyte management in this complex clinical scenario.

2 contributors 72 votes 6 Apr 2026

TDX-2026-00014

Optimizing Mechanical Ventilation in Obese Patients with Moderate Acute Respiratory Distress Syndrome: A Consensus-Based Approach to Driving Pressure, Plateau Pressure, and Adjunctive Therapies

Mechanical ventilation in patients with Acute Respiratory Distress Syndrome (ARDS) is complex, with obesity presenting unique challenges due to altered respiratory mechanics. This paper synthesizes expert clinical opinions from a specialized medical discussion forum, addressing critical questions regarding ventilator management in obese ARDS patients. The discussion centered on a 55-year-old obese female with moderate ARDS (P/F ratio 142), highlighting the interplay between plateau pressure, driving pressure, and adjunctive strategies. Experts advocate for tolerating higher plateau pressures (up to 33-35 cmH2O) in obese individuals, provided driving pressure remains below 15 cmH2O, acknowledging the significant contribution of chest wall elastance to airway pressure in this population. Driving pressure is emphasized as the primary ventilator target, aligning with evidence suggesting its superior predictive value for mortality. Early prone positioning is strongly recommended for eligible patients, particularly in obesity, due to its enhanced mechanical benefits. The routine use of esophageal balloon manometry for transpulmonary pressure measurement is endorsed, especially in obese patients, to personalize ventilation strategies. Practical considerations for safe prone positioning in obese patients are also detailed. This consensus highlights a shift towards individualized, physiology-guided ventilation, prioritizing transpulmonary and driving pressures while integrating evidence-based adjunctive therapies to mitigate ventilator-induced lung injury and improve outcomes in this challenging patient cohort.

3 contributors 67 votes 6 Apr 2026

TDX-2026-00012

Optimizing Malignant Hyperthermia Management: A Peer-Reviewed Consensus on Dantrolene Reconstitution and Crisis Protocols

Background: Malignant Hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder triggered by volatile anesthetics and succinylcholine. Rapid diagnosis and immediate administration of dantrolene are critical for patient survival. However, the traditional reconstitution process for dantrolene sodium can be time-consuming, potentially delaying definitive treatment during an acute crisis. This paper synthesizes expert opinions on practical solutions to mitigate these delays and optimize overall MH management. Methods: This study utilized a community peer-reviewed clinical Q&A discussion platform, tachyDx, involving two verified physician contributors and garnering 55 peer votes. The discussion focused on practical challenges related to dantrolene reconstitution during suspected MH and parallel management strategies. Expert responses were analyzed to identify consensus and divergent practices regarding dantrolene stocking, availability of concentrated formulations, concurrent therapeutic interventions, and post-crisis monitoring. Results: Key findings include a consensus on increased dantrolene stocking (e.g., 36 vials of classic dantrolene) and the significant advantage of concentrated formulations like Ryanodex for rapid administration. Parallel management strategies emphasized immediate anesthetic cessation, hyperventilation, aggressive active cooling, and prompt treatment of hyperkalemia. Post-crisis care protocols highlighted the necessity for continuous monitoring in an intensive care unit for at least 24 hours, serial laboratory assessments, maintenance dantrolene dosing, and crucial genetic counseling for affected families. Conclusions: Efficient dantrolene administration, supported by adequate stocking, rapid-reconstitution formulations, and well-drilled parallel management protocols, is paramount in MH crisis. Comprehensive post-crisis care, including genetic counseling, is essential for patient safety and family screening. These insights underscore the need for robust institutional protocols and continuous education to improve outcomes in MH.

2 contributors 55 votes 6 Apr 2026

TDX-2026-00006

Management of Thyroid Storm with Severe Asthma: A Community Peer-Reviewed Clinical Consensus on Non-Beta-Blocker Rate Control and Adjunctive Therapies

Thyroid storm represents a life-threatening endocrine emergency characterized by exaggerated manifestations of thyrotoxicosis. Rapid heart rate control is critical, typically achieved with beta-adrenergic receptor blockers. However, the presence of severe comorbid conditions, such as severe asthma, can contraindicate standard beta-blocker therapy, posing a significant clinical challenge. This paper synthesizes a clinical discussion from the tachyDx community peer-review platform regarding the optimal management strategy for a 28-year-old male presenting with thyroid storm and severe asthma, specifically focusing on rate control alternatives and comprehensive adjunctive treatments. Methods: This case-based discussion was initiated by a verified endocrinologist on a specialized clinical Q&A platform, attracting input from another verified physician and garnering 68 community peer votes. The methodology involved expert clinical opinion exchange, evaluation of therapeutic alternatives, and consensus building on a complex patient presentation. The final management approach, which led to a successful clinical outcome, was subsequently shared and validated. Results: The consensus approach involved intravenous diltiazem for heart rate control, achieving a reduction from 156 to 94 bpm within four hours without precipitating bronchospasm. The comprehensive thyroid storm regimen included propylthiouracil (PTU), saturated solution of potassium iodide (SSKI), hydrocortisone, and cholestyramine. This multifaceted intervention resulted in a dramatic clinical improvement, with the Burch-Wartofsky score decreasing from 55 to 20 within three days. Conclusions: Diltiazem emerges as a safe and effective alternative for rapid heart rate control in thyroid storm patients with severe asthma where beta-blockers are contraindicated. The case reinforces the importance of a multi-modal therapeutic strategy targeting hormone synthesis, release, peripheral conversion, and enterohepatic recirculation, tailored to individual patient comorbidities.

2 contributors 68 votes 6 Apr 2026

TDX-2026-00003

Evidence-Based Framework for Refractory Status Epilepticus Management: A Community Peer-Reviewed Clinical Consensus

Background: Refractory status epilepticus (RSE) represents a neurological emergency associated with significant morbidity and mortality, characterized by persistent seizure activity despite the administration of adequate doses of at least two antiepileptic drugs, including a benzodiazepine. Optimal management strategies for RSE, particularly regarding continuous infusion agents, electroencephalographic targets, and the timing of etiologic investigations, remain subjects of ongoing clinical debate and require expert consensus. Methods: This paper synthesizes expert opinions derived from a structured, community peer-reviewed clinical discussion on the tachyDx platform. Three verified physicians, specializing in neurology and critical care, contributed to a case-based scenario of a 32-year-old female presenting with new-onset RSE. Their responses underwent peer evaluation by 106 community physicians. Results: Consensus emerged on several critical aspects of RSE management. Midazolam infusion was favored over propofol as a first-line continuous agent due to concerns regarding Propofol Infusion Syndrome (PRIS). The initial electroencephalographic target was seizure suppression, with escalation to burst-suppression reserved for persistent seizures. Infusions were typically maintained for 24-48 hours post-seizure cessation. Ketamine was identified as a valuable second-line continuous infusion. Early immunologic workup, particularly for anti-NMDA receptor encephalitis, was strongly recommended in new-onset RSE without clear etiology. Meticulous hemodynamic and electrolyte management was emphasized. Conclusions: The synthesized expert consensus provides a practical, evidence-informed framework for managing RSE, highlighting the importance of a multidisciplinary approach, careful agent selection, individualized electroencephalographic targets, and prompt etiologic investigation, especially for autoimmune causes.

3 contributors 106 votes 6 Apr 2026

TDX-2026-00001

Evidence-Based Framework for Vasopressor and Inotrope Sequencing in Septic Shock with Concurrent Right Ventricular Failure: A Community Peer-Reviewed Clinical Consensus

Background: Septic shock frequently leads to complex hemodynamic instability, often complicated by acute right ventricular (RV) failure. This co-occurrence significantly increases morbidity and mortality, presenting a therapeutic challenge due to the intricate interplay between systemic vasodilation, elevated pulmonary vascular resistance (PVR), and myocardial dysfunction. Optimal vasopressor and inotropic agent sequencing in this specific clinical scenario remains a subject of ongoing debate and lacks definitive guideline recommendations. Methods: This consensus paper synthesizes expert opinions from a clinical Q&A discussion hosted on a specialized physician peer-review platform. Five verified critical care and cardiology specialists contributed to the discussion, which garnered 130 community peer votes. The methodology involved a structured analysis of proposed treatment algorithms, evaluation of supporting evidence, and identification of key monitoring parameters to establish a practical, stepwise approach. Results: A consensus emerged advocating for early initiation of vasopressin (0.03-0.04 U/min) as an adjunct to norepinephrine, prioritizing its favorable PVR profile over further norepinephrine escalation. Low-dose dobutamine (2.5-5 mcg/kg/min) was recommended for targeted RV inotropic support once mean arterial pressure was stabilized. In cases of refractory RV dysfunction, inhaled epoprostenol (20-50 ng/kg/min) was endorsed for selective pulmonary vasodilation. Agents such as phenylephrine and milrinone were strongly discouraged due to their potential to exacerbate RV afterload or systemic hypotension, respectively. Conclusions: This consensus provides a structured, evidence-informed approach to vasopressor and inotrope sequencing in septic shock with concurrent RV failure. The recommendations emphasize a physiologically guided strategy, prioritizing agents that minimize RV afterload while supporting contractility, alongside vigilant hemodynamic and echocardiographic monitoring. This framework aims to guide clinicians in managing this high-risk patient population.

5 contributors 130 votes 6 Apr 2026
Page 1 of 2Next →

Topics

Allpharmacology8critical-care7cardiology6emergency-medicine6oncology5pulmonology5nephrology4neurology4gastroenterology3immunology3hematology3infectious-disease3surgery3radiology2endocrinology2anesthesiology2hepatology2pediatrics2rheumatology2evidence-based-medicine1orthopedics1trauma1neonatology1psychiatry1internal-medicine1